1,686 results on '"Ebert, Matthias"'
Search Results
2. Privacy-preserving large language models for structured medical information retrieval
3. Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients
4. Unveiling the culprit: the fusobacterium lineage that populates colorectal cancer
5. Clinical impact of panel gene sequencing on therapy of advanced cancers of the digestive system: a retrospective, single center study
6. A systematic review of diagnostic and interventional techniques in non-occlusive hepatic artery hypoperfusion syndrome
7. Aktualisierte S3-Leitlinie „Diagnostik und Therapie der Plattenepithel- und Adenokarzinome des Ösophagus (Version 4.0)“
8. Evaluation of four chatbots in autoimmune liver disease: A comparative analysis
9. Deep sight: enhancing periprocedural adverse event recording in endoscopy by structuring text documentation with privacy-preserving large language models
10. The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects
11. Functional status and quality of life in older patients with advanced esophageal squamous cell cancer receiving second-line nivolumab ± ipilimumab therapy: A post hoc analysis of the phase 2, multicenter RAMONA study
12. Potential role of Vitamin D in immune response in patients with viral hepatitis
13. Serum Glial Cell Line-Derived Neurotrophic Factor (sGDNF) Is a Novel Biomarker in Predicting Cirrhosis in Patients with Chronic Hepatitis B
14. Engineering the gut microbiome
15. Deep learning-based subtyping of gastric cancer histology predicts clinical outcome: a multi-institutional retrospective study
16. Myotubularin-related-protein-7 inhibits mutant (G12V) K-RAS by direct interaction
17. Characteristics and outcome of patients with small bowel adenocarcinoma (SBA)
18. Nuclear pore protein POM121 regulates subcellular localization and transcriptional activity of PPARγ
19. Microbiome in Gastric Cancer
20. The Interplay of TGF-β1 and Cholesterol Orchestrating Hepatocyte Cell Fate, EMT, and Signals for HSC Activation
21. Insulin Determines Transforming Growth Factor β Effects on Hepatocyte Nuclear Factor 4α Transcription in Hepatocytes
22. Deep learning trained on lymph node status predicts outcome from gastric cancer histopathology: a retrospective multicentric study
23. Impact of etiology on disease course in chronic pancreatitis
24. Intestinal BMP-9 locally upregulates FGF19 and is down-regulated in obese patients with diabetes
25. Tolerance of repeated toxic injuries of murine livers is associated with steatosis and inflammation
26. Second Cancer After Additive Chemotherapy in Patients With Colon Cancer
27. The gut virome: A new microbiome component in health and disease
28. Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial
29. Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer - Results from a prospective phase IV clinical trial
30. Hepatic bile acid accretion correlates with cholestatic liver injury and therapeutic response in Cyp2c70 knockout mice with a humanized bile acid composition.
31. Associations Between Brain Morphology, Inflammatory Markers, and Symptoms of Fatigue, Depression, or Anxiety in Active and Remitted Crohn's Disease.
32. Conservative versus surgical therapy for idiopathic and secondary megacolon or megarectum in adults – a retrospective multicentre controlled study.
33. Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial
34. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
35. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study
36. Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
37. Situation klinischer Studien in Deutschland – ein interdisziplinäres Positionspapier
38. Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study
39. The drug-induced phenotypic landscape of colorectal cancer organoids
40. Depression and fatigue in active IBD from a microbiome perspective—a Bayesian approach to faecal metagenomics
41. Functional antagonism between CagA and DLC1 in gastric cancer
42. An organoid platform reveals MEK-PARP co-targeting to enhance radiation response in rectal cancer
43. FRI-539 EGF/STAT1 signals to maintain ECM1 expression in hepatic homeostasis are disrupted by IFNγ/NRF2 in chronic liver disease
44. THU-164-YI Evaluation of four chatbots in autoimmune liver disease: a comparative analysis
45. Current Trends and Advancements in the Management of Hepatocellular Carcinoma
46. Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort study
47. Retinoic acid generates a beneficial microenvironment for liver progenitor cell activation in acute liver failure.
48. Loss analysis and optimization of PV module components and design to achieve higher energy yield and longer service life in desert regions
49. Beurteilung des neuen Masernschutzgesetzes in Deutschland: Ergebnisse einer deutschlandweiten Befragung
50. Benefit of adjuvant chemotherapy in high-risk colon cancer: A 17-year population-based analysis of 6131 patients with Union for International Cancer Control stage II T4N0M0 colon cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.